Study of Direct Selective Laser Trabeculoplasty DSLT to Lower Eye Pressure in Black African Adults with Mild to Moderate Open Angle Glaucoma

What this Trial Is About

Researchers are evaluating how well Direct Selective Laser Trabeculoplasty DSLT lowers eye pressure in adult non-Caucasian patients with primary open angle glaucoma POAG. The study focuses on comparing eye pressure without glaucoma medications washed out eye pressure before and 6 months after the DSLT procedure. This research aims to better understand the effectiveness of DSLT in lowering intraocular pressure in this patient group. Participants will receive the DSLT treatment using the Belkin Vision Eagle Device on one or both eyes. The study includes follow-up visits at 1 month, 3 months, and 6 months after the procedure to monitor vision and eye pressure. These visits assess the reduction in eye pressure and whether participants need additional glaucoma medications or procedures during the 6 months after treatment. During the study, participants will have their vision and intraocular pressure measured at scheduled visits. Researchers will track the amount of eye pressure reduction, the proportion of eyes achieving significant pressure decrease, and the number of medication-free eyes at 6 months. Safety and the need for any extra glaucoma treatments will also be monitored. The total study duration for each participant is 6 months after the DSLT procedure.

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma